C. Lapenta

发表

IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing.

V. Barnaba, F. Belardelli, F. Spadaro, 2012, Blood.

Human intestinal lamina propria lymphocytes are naturally permissive to HIV‐1 infection

F. Belardelli, C. Lapenta, S. Santini, 1999, European journal of immunology.

Advances and perspectives of dendritic cell-based active immunotherapies in follicular lymphoma

C. Lapenta, S. Santini, M. Cox, 2020, Cancer Immunology, Immunotherapy.

Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19

K. Ozato, C. Lapenta, S. Santini, 2020, Cytokine & Growth Factor Reviews.

IFN‐α‐conditioned dendritic cells are highly efficient in inducing cross‐priming CD8+ T cells against exogenous viral antigens

D. Accapezzato, V. Barnaba, F. Belardelli, 2006, European journal of immunology.

Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial

S. Hohaus, A. Tafuri, D. Prosperi, 2019, Clinical Cancer Research.

Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells.

A. Costantino, E. Tritarelli, C. Marcantonio, 2011, Vaccine.

SCID Mice Transplanted With Human Cells as Small Animal Models in AIDS Research

F. Belardelli, C. Lapenta, S. Santini, 2006 .

Type I interferons as regulators of the differentiation/activation of human dendritic cells: methods for the evaluation of IFN-induced effects.

F. Belardelli, C. Lapenta, S. Santini, 2005, Methods in molecular medicine.

A New Type I IFN‐Mediated Pathway for the Rapid Differentiation of Monocytes into Highly Active Dendritic Cells

T. Di Pucchio, F. Belardelli, C. Lapenta, 2003, Stem cells.

U937-SCID mouse xenografts: a new model for acute in vivo HIV-1 infection suitable to test antiviral strategies.

E. Proietti, F. Belardelli, C. Lapenta, 1997, Antiviral research.

T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells

G. Gherardi, F. Belardelli, P. Sestili, 1996, Journal of virology.

THE SCID MOUSE REACTION TO HUMAN PERIPHERAL BLOOD MONONUCLEAR LEUKOCYTE ENGRAFTMENT: NEUTROPHIL RECRUITMENT INDUCED EXPRESSION OF A WIDE SPECTRUM OF MURINE CYTOKINES AND MOUSE LEUKOPOIESIS, INCLUDING THYMIC DIFFERENTIATION

G. Gherardi, F. Belardelli, P. Sestili, 1995, Transplantation.

IFN-alpha in the generation of dendritic cells for cancer immunotherapy.

F. Belardelli, C. Lapenta, S. Santini, 2009, Handbook of experimental pharmacology.

potent migratory and functional activities monocyte-derived dendritic cells : importance for the rapid acquisition of , and Th1 chemokines in type I IFN-induced β Expression

F. Belardelli, C. Lapenta, S. Santini, 2001 .

CD2+/CD14+ monocytes rapidly differentiate into CD83+ dendritic cells

F. Belardelli, C. Lapenta, S. Santini, 2003, European journal of immunology.

Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice

F. Belardelli, C. Lapenta, E. Garaci, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine

F. Belardelli, P. Sestili, F. Spadaro, 2019, Cancer Immunology, Immunotherapy.

Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12

F. Belardelli, F. Spadaro, C. Lapenta, 2011, PloS one.

NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients

F. Belardelli, F. Spadaro, C. Lapenta, 2016, The Journal of Immunology.

Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.

E. Proietti, F. Belardelli, C. Lapenta, 1999, Virology.

Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.

P. Di Bonito, F. Grasso, S. Mochi, 2009, Virology.

Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides

E. Proietti, F. Belardelli, P. Sestili, 2001, AIDS.

Potent Immune Response against HIV-1 and Protection from Virus Challenge in hu-PBL-SCID Mice Immunized with Inactivated Virus-pulsed Dendritic Cells Generated in the Presence of IFN-α

T. Di Pucchio, F. Belardelli, C. Lapenta, 2003, The Journal of experimental medicine.

Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice

T. Di Pucchio, F. Belardelli, C. Lapenta, 2000, The Journal of experimental medicine.

Human Immunodeficiency Virus Type 1 Strains R5 and X4 Induce Different Pathogenic Effects in hu-PBL-SCID Mice, Depending on the State of Activation/Differentiation of Human Target Cells at the Time of Primary Infection

F. Belardelli, C. Lapenta, S. Santini, 1999, Journal of Virology.

Differentiation of monocyte‐derived dendritic cells is associated with upregulation and activation of Rac‐1 small GTPase

F. Belardelli, C. Lapenta, S. Santini, 2006, FEBS letters.

Primary HIV-1 infection of human CD4+ T cells passaged into SCID mice leads to selection of chronically infected cells through a massive Fas-mediated autocrine suicide of uninfected cells

E. Proietti, F. Belardelli, C. Lapenta, 2000, Cell Death and Differentiation.

Human Lymphoblastoid CD4+ T Cells Become Permissive to Macrophage-Tropic Strains of Human Immunodeficiency Virus Type 1 after Passage into Severe Combined Immunodeficient Mice through In Vivo Upregulation of CCR5: In Vivo Dynamics of CD4+ T-Cell Differentiation in Pathogenesis of AIDS

E. Proietti, F. Belardelli, C. Lapenta, 1998, Journal of Virology.

Treatment of severe combined immunodeficiency mice with anti-murine granulocyte monoclonal antibody improves human leukocyte xenotransplantation.

E. Proietti, F. Belardelli, C. Lapenta, 1998, Transplantation.

Interferon-alpha enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing and processing.

V. Barnaba, F. Belardelli, F. Spadaro, 2011 .

Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities.

T. Di Pucchio, F. Belardelli, C. Lapenta, 2001, Blood.

The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity.

T. Di Pucchio, F. Belardelli, C. Lapenta, 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

IFN-Alpha-Mediated Differentiation of Dendritic Cells for Cancer Immunotherapy: Advances and Perspectives

C. Lapenta, S. Santini, L. Gabriele, 2020, Vaccines.

Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy

A. Weisz, F. Belardelli, B. Zeng, 2017, Oncoimmunology.

Epstein‐Barr virus infection induces miR‐21 in terminally differentiated malignant B cells

L. Frati, F. Belardelli, E. Anastasiadou, 2015, International journal of cancer.

In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma.

G. Filomeni, A. Caccuri, G. Federici, 2009, European journal of cancer.

Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.

F. Belardelli, C. Lapenta, S. Santini, 2005, International immunology.

IFN-alpha in the generation of dendritic cells for cancer immunotherapy.

F. Belardelli, C. Lapenta, S. Santini, 2009, Handbook of experimental pharmacology.